13 results
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /diagnosis and treatment ... #Deficiency #Management ... #HFrEF #sCHF #HeartFailure ... #Cardiology #Indications
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Iron Deficiency ... Treatment Algorithm ... deficiency #CHF #HFrEF #heartfailure ... #diagnosis #management ... #algorithm #cardiology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Iron Deficiency ... Heart Failure Pathophysiology ... deficiency #CHF #HFrEF #heartfailure ... #diagnosis #management ... #cardiology
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
American College of Cardiology ... Practice Guidelines and ... America #HFrEF #HeartFailure ... guideline #ACCAHA2017 #cardiology ... #treatment #algorithm
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Quality of life and ... Higher NT-proBNP and ... #Failure #CHF #pharmacology ... #pathophysiology ... #cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF and ... circulatory support; and ... CHF #Congestive #HeartFailure ... Stages #ACCAHA #Algorithm ... #Management #Cardiology
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
help prolong life and ... cause class III and ... #Management #Cardiology ... CHF #Congestive #HeartFailure ... Stages #ACCAHA #Algorithm
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
response to the drug, and ... severe bleeding and ... #management #algorithm ... #pharmacology # ... #decisionaid #cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
→ no signs of CXR ... endomyocardial biopsy Pharmacology ... Jcortesizaguirr #HFrEF #heartfailure ... #diagnosis #management ... #cardiology #pharmacology
Antiarrhythmics - Vaughan Williams Classification:
CLASS 1 - Sodium Channel Blockers:
 • MOA: Block fast Na+ channels
reduce speed of ion ... inotropy) ACCP Cardiology ... Vaughan #Williams #Pharmacology ... Classification #Classes #pathophysiology ... #cardiology